Dupilumab Approved for Chronic Spontaneous Urticaria
18-04-2025 19:06 via medscape.com

Dupilumab Approved for Chronic Spontaneous Urticaria

Resubmission of the supplemental biologics license application provided more data on improvement in hives and itching in patients ages 12 and older with CSU.Medscape Medical News
Read more »

Nurse news



Ivarmacitinib Provides Relief in Atopic Dermatitis Study
Ivarmacitinib Provides Relief in Atopic Dermatitis Study
Emerging Biomarkers and Treatments in Anal Cancer
Emerging Biomarkers and Treatments in Anal Cancer
Highlights in Myasthenia Gravis From AAN 2025
Highlights in Myasthenia Gravis From AAN 2025
Real-World Data Support Febuxostat’s Cardiovascular Safety
Real-World Data Support Febuxostat’s Cardiovascular Safety
Ritlecitinib plus nbUVB improves vitiligo repigmentation
Ritlecitinib plus nbUVB improves vitiligo repigmentation
US Alzheimer’s Prevalence Surpasses 7 Million
US Alzheimer’s Prevalence Surpasses 7 Million
Atopy Rises in Indian Immigrant Kids, Study Finds
Atopy Rises in Indian Immigrant Kids, Study Finds
Fewer Permanent Nurses on Wards Link to Higher Death Rates
Fewer Permanent Nurses on Wards Link to Higher Death Rates
Doctor Aids In-Air Emergency Birth — With a Wild Plot Twist
FDA Approves First One-Time Treatment for RDEB Wounds
Is BMI Still the Best Tool for Assessing Weight?
FDA Okays Upadacitinib for Giant Cell Arteritis
Key Updates in RRMS From AAN 2025
Initial DMT Selection in MS: Balancing Risks and Goals
Desktop versie